QIAGEN NV EO -,01 | 44.060 / +0.55% |
Date/Time | 01/18 / 10:00 |
Chg. / Chg.(%) | 0.240 / +0.55% |
Bid | 44.130 / 323 |
Ask | 44.130 / 506 |
Open | 44.070 |
Previous Close | 43.820 |
High | 44.200 |
Low | 43.960 |
Volume [EUR] | 92,796.750 |
Volume [Units] | 2,102 |
Price fixings | 13 |
ISIN | NL0012169213 |
Security | QIA |
Exchange | Stuttgart |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
Xetra | 44.120 | ![]() |
18,323 |
Cboe Europe .. | 44.13 | ![]() |
8,437 |
TradeGate | 44.29 | ![]() |
4,264 |
Turquoise | 44.17 | ![]() |
3,886 |
Stuttgart | 44.060 | ![]() |
2,102 |
Frankfurt | 44.1700 | ![]() |
569 |
Cboe Europe .. | 44.15 | ![]() |
236 |
London Inter.. | 44.16 | ![]() |
122 |
gettex | 44.160 | ![]() |
100 |
Hannover | 44.040 | ![]() |
83 |
Vienna Globa.. | 43.95 | ![]() |
0 |
München | 44.110 | ![]() |
0 |
Düsseldorf | 44.080 | ![]() |
0 |
Hamburg | 44.080 | ![]() |
0 |
Berlin | 44.060 | ![]() |
0 |
Lang & Schwa.. | 44.120 | ![]() |
|
NYSE | 53.20 | ![]() |
558,329 |
Cboe US | 53.11 | ![]() |
11,857 |
IEX | 53.19 | ![]() |
5,873 |
Cboe Europe .. | 43.93 | 1,029 | |
EUREX | Options |
News
- OpGen Announces Planned Leadership Transition at Next Generation Sequencing and Bioinformatics Subsidiary Ares Genetics
12/09/2020 / 13:30 - GlobeNewswire - HTG Molecular Diagnostics Reports Third Quarter 2020 Results
11/10/2020 / 22:01 - GlobeNewswire - Ellume Secures $30M from National Institutes of Health RADx Initiative to Accelerate Development of Rapid COVID-19 Diagnostics
10/06/2020 / 21:30 - GlobeNewswire - Thermo Fisher's acquisition of Qiagen fails
08/13/2020 / 13:48 - TeleTrader - HTG Molecular Diagnostics Reports Second Quarter 2020 Results
08/11/2020 / 22:01 - GlobeNewswire